Dopamine: from pharmacology to molecular biology and back

Carlsson A, Lindqvist M, Magnusson T, Waldeck B (1958) On the presence of 3-hydroxytyramine in brain. Science 127: 471PubMedCrossRefGoogle Scholar

Ehringer A, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien Klin Wochenschr 38: 1236–1239Google Scholar

Birkmayer W, Hornykiewicz O (1961) The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia. Wien Klin Wochenschr 73: 787–788PubMedGoogle Scholar

Kebabian JW, Greengard P (1971) Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission. Science 174: 1346–1349PubMedCrossRefGoogle Scholar

Seeman P, Chau-Wong M, Tedesco J, Wong K (1975) Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci USA 72: 4376–4380PubMedCrossRefGoogle Scholar

Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481–483PubMedCrossRefGoogle Scholar

Caron MG, Beaulieu M, Raymond V, Gagne B, Drouin J, Lefkowitz RJ, et al (1978) Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydro-ergocryptine binding with the dopaminergic control of prolactin release. J Biol Chem 253: 2244–2253PubMedGoogle Scholar

Garau L, Govoni S, Stefanini E, Trabucchi M, Spano PF (1978) Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci 23: 1745–1750PubMedCrossRefGoogle Scholar

Amlaiky N, Caron MG (1985) Photoaffinity labeling of the D2-dopamine receptor using a novel high affinity radioiodinated probe. J Biol Chem 260: 1983–1986PubMedGoogle Scholar

Amlaiky N, Berger JG, Chang W, McQuade RJ, Caron MG (1987) Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking. Mol Pharmacol 31: 129–134PubMedGoogle Scholar

Senogles SE, Amlaiky N, Falardeau P, Caron MG (1988) Purification and characterization of the D2-dopamine receptor from bovine anterior pituitary. J Biol Chem 263: 18996–19002PubMedGoogle Scholar

Gingrich JA, Dearry A, Falardeau P, Fremeau RT Jr, Bates MD, Caron MG (1991) Molecular characterization of G-protein coupled receptors: isolation and cloning of a D1 dopamine receptor. J Recept Res 11: 521–534PubMedGoogle Scholar

Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, et al (1986) Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321: 75–79PubMedCrossRefGoogle Scholar

Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M, et al (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 336: 783–787PubMedCrossRefGoogle Scholar

Dearry A, Gingrich JA, Falardeau P, Fremeau RT Jr, Bates MD, Caron MG (1990) Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347: 72–76PubMedCrossRefGoogle Scholar

Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146–151PubMedCrossRefGoogle Scholar

Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, et al (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610–614PubMedCrossRefGoogle Scholar

Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, et al (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350: 614–619PubMedCrossRefGoogle Scholar

Tiberi M, Jarvie KR, Silvia C, Falardeau P, Gingrich JA, Godinot N, et al (1991) Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc Natl Acad Sci USA 88: 7491–7495PubMedCrossRefGoogle Scholar

Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350: 350–354PubMedCrossRefGoogle Scholar

Guastella J, Nelson N, Nelson H, Czyzyk L, Keynan S, Miedel MC, et al (1990) Cloning and expression of a rat brain GABA transporter. Science 249: 1303–1306PubMedCrossRefGoogle Scholar

Giros B, el Mestikawy S, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295: 149–154PubMedCrossRefGoogle Scholar

Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606–612PubMedCrossRefGoogle Scholar

Gainetdinov RR, Caron MG (2003) Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43: 261–284PubMedCrossRefGoogle Scholar

Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR (2005) Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol 3: e271PubMedCrossRefGoogle Scholar

Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, et al (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98: 8966–8971PubMedCrossRefGoogle Scholar

Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, et al (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60: 1181–1188PubMedGoogle Scholar

Costa RM, Lin SC, Sotnikova TD, Cyr M, Gainetdinov RR, Caron MG, et al (2006) Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron (in press)Google Scholar

Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, et al (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 101: 5099–5104PubMedCrossRefGoogle Scholar

Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261–273PubMedCrossRefGoogle Scholar

Hornykiewicz O (2002) L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Amino Acids 23: 65–70PubMedCrossRefGoogle Scholar